More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Jeremy Pappacena; Valkal Bhatt; Gunjan L. Shah; Patrick Hilden; Molly Maloy; Larry W. Buie; Sergio A. Giralt; Michael Scordo

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

【24h】

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共2页
作者
Jeremy Pappacena; Valkal Bhatt; Gunjan L. Shah; Patrick Hilden; Molly Maloy; Larry W. Buie; Sergio A. Giralt; Michael Scordo;
展开▼
作者单位

Department of Pharmacy Memorial Sloan Kettering Cancer Center;

Department of Pharmacy Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Biostatistics and Epidemiology Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Pharmacy Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

Department of Medicine Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献

1. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [J] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性
2. Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia [J] . Kebriaei Partow, Wei Wei, Thall Peter F., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：白消安（Bu）与双核苷类似物氟达拉滨（Flu）和氯法拉滨（Clo）加上伏立诺他合作为急性白血病患者（pts）同种异体造血细胞移植（HCT）的新型毒性降低的条件疗法
3. Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation [J] . Ueda Tomoaki, Maeda Tetsuo, Kusakabe Shinsuke, International journal of hematology . 2019,第2期

机译：将Melphalan添加到Fludarabine / Busulfan（Fly / Bu4 / Mel）为骨髓性骨髓移植/外周血茎细胞移植组成后骨髓恶性肿瘤患者提供生存益处
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Busulfan-based Reduced Toxicity Conditioning [O] . Mehdi Hamadani, Michael Craig, Gary S. Phillips, -1

机译：较高的Busulfan剂量强度并未改善氟胺基于Busulfan的毒性调理后进行同种异体造血细胞移植患者的结果
6. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [O] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, 2018

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

著录项

相似文献

相关主题

期刊订阅